Concert Pharmaceuticals, Inc. Operating Cash Flow
Concert Pharmaceuticals, Inc. reported Operating Cash Flow of -$83.19 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-07
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$25.96M.
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$24.90M, a 333.31% decline year-over-year.
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$32.32M.
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$26.48M.
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$55.15M.
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$69.04M.
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$48.76M.
- Concert Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$48.03M, a 146.14% decline from fiscal 2017.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$25.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$50.86M derived: sum of 2 quarters · filed 2022-11-07 | -$83.19M 10-Q · filed 2022-11-07 | -$109.66M derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | -$24.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$57.23M 10-Q · filed 2022-08-04 | -$83.70M derived: sum of 3 quarters · filed 2022-08-04 | -$102.34M derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-03-31 | -$32.32M 10-Q · filed 2022-05-05 | -$58.80M derived: sum of 2 quarters · filed 2022-05-05 | -$77.44M derived: sum of 3 quarters · filed 2022-11-07 | -$66.76M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-12-31 | -$26.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$45.11M derived: sum of 2 quarters · filed 2022-11-07 | -$34.44M derived: sum of 3 quarters · filed 2022-11-07 | -$55.15M 10-K · filed 2022-03-03 |
| 2021-09-30 | -$18.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$7.96M derived: sum of 2 quarters · filed 2022-11-07 | -$28.68M 10-Q · filed 2022-11-07 | -$44.90M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $10.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$10.04M 10-Q · filed 2022-08-04 | -$26.27M derived: sum of 3 quarters · filed 2022-08-04 | -$46.55M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$20.71M 10-Q · filed 2022-05-05 | -$36.94M derived: sum of 2 quarters · filed 2022-05-05 | -$57.23M derived: sum of 3 quarters · filed 2022-05-05 | -$71.92M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$36.51M derived: sum of 2 quarters · filed 2022-03-03 | -$51.20M derived: sum of 3 quarters · filed 2022-03-03 | -$69.04M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$20.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$34.98M derived: sum of 2 quarters · filed 2021-11-09 | -$52.81M 10-Q · filed 2021-11-09 | -$67.89M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$14.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$32.52M 10-Q · filed 2021-08-05 | -$47.60M derived: sum of 3 quarters · filed 2021-08-05 | -$63.26M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$17.83M 10-Q · filed 2021-05-04 | -$32.91M derived: sum of 2 quarters · filed 2021-05-04 | -$48.57M derived: sum of 3 quarters · filed 2021-05-04 | -$65.26M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | -$15.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$30.74M derived: sum of 2 quarters · filed 2021-02-25 | -$47.42M derived: sum of 3 quarters · filed 2021-02-25 | -$48.76M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$15.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$32.35M derived: sum of 2 quarters · filed 2020-11-05 | -$33.69M 10-Q · filed 2020-11-05 | -$49.30M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$16.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$18.02M 10-Q · filed 2020-08-06 | -$33.64M derived: sum of 3 quarters · filed 2020-08-06 | -$44.85M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$1.34M 10-Q · filed 2020-04-30 | -$16.95M derived: sum of 2 quarters · filed 2020-04-30 | -$28.16M derived: sum of 3 quarters · filed 2020-04-30 | -$36.88M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | -$15.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$26.82M derived: sum of 2 quarters · filed 2020-02-27 | -$35.54M derived: sum of 3 quarters · filed 2020-02-27 | -$48.03M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$11.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$19.93M derived: sum of 2 quarters · filed 2019-11-07 | -$32.41M 10-Q · filed 2019-11-07 | -$38.77M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$8.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$21.20M 10-Q · filed 2019-08-01 | -$27.56M derived: sum of 3 quarters · filed 2019-08-01 | |
| 2018-03-31 | -$12.48M 10-Q · filed 2019-05-02 | -$18.84M derived: sum of 2 quarters · filed 2019-05-02 | ||
| 2017-12-31 | -$6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $104.08M 10-K · filed 2019-02-28 | ||
| 2017-09-30 | $110.44M 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | -$45.34M 10-K · filed 2019-02-28 | |||
| 2014-06-30 | -$7.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$15.21M 10-Q · filed 2014-08-12 | ||
| 2014-03-31 | -$8.10M 10-Q · filed 2014-05-14 | |||
| 2013-06-30 | $28.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $26.70M 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | -$2.09M 10-Q · filed 2014-05-14 |